Detalhe da pesquisa
1.
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network.
Rheumatology (Oxford);
2024 Mar 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38530774
2.
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership.
Rheumatology (Oxford);
61(11): 4335-4343, 2022 11 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35212719
3.
Sex-specific peripheral and central responses to stress-induced depression and treatment in a mouse model.
J Neurosci Res;
98(12): 2541-2553, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32918293
4.
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination.
Arthritis Rheumatol;
74(2): 284-294, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34347939
5.
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort.
Lancet Rheumatol;
3(8): e585-e594, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34075358
6.
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network.
Lupus Sci Med;
8(1)2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34389634
7.
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus Erythematosus.
Arthritis Rheumatol;
72(12): 1971-1980, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32715660